Local Business Briefs - 11/14 (The Press-Enterprise)
Watson Pharmaceuticals Inc. will seek approval for a new drug that helps treat advanced prostate cancer, according to a statement from the Corona company released Thursday.
Losses no problem for GTx stock (Memphis Commercial Appeal)
Memphis-based drug company GTx Inc. reported more losses this week as it continues its expensive quest to bring new medicines onto the market. Third-quarter losses were $11.9 million, or 33 cents per share, larger than the losses of $10.2 million and 29 cents per share in the year-ago quarter.
Dendreon 3Q loss grows on stock warrant charge (INO News)
(AP:SEATTLE) Drug developer Dendreon Corp. on Friday said expenses connected to its April stock offering pushed its third-quarter loss up 39 percent. The company's loss expanded to $26.8 million, or 29 cents per share, from $19.2 million, or 23 cents per share, a year earlier.